I'm cautious about Novo Nordisk's short-term prospects due to the recent selloff, but see long-term potential with high ...
According to the American Diabetes Association, approximately 8.4 million people in the United States need insulin to survive ...
Turning to 2025 guidance, Lilly noted that new medicines and new uses of existing medicines, expansion of production, and ...
After coming to the US in 1982, it underwent several corporate changes until becoming Novo Nordisk in 1989. In addition to diabetes drugs, the company also makes drug treatments for wound healing ...
The head of Ozempic maker Novo Nordisk A/S is among business executives who are meeting the Danish prime minister to discuss ...
The Baltimore City Board of School Commissioners is suing Eli Lilly and Co., UnitedHealth Group, CVS and several other drug ...
January is a big time for drugmakers to hike prices. This year saw higher prices for 575 medications so far, including ...
During JPM week, virtual care companies strut their plans to make GLP-1 drugs work harder, cost less
Digital health companies' plans focused on managing the impact of GLP-1 drugs, which have placed enormous pressure on health ...
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
A new request by Ozempic manufacturer Novo Nordisk could limit the availability of a type of GLP-1—semaglutides—to local ...
Eli Lilly and other drugmakers are reportedly planning to urge the Trump administration to pause Medicare drug-price ...
Novo Nordisk says an oral drug which can help type 2 diabetes patients to lower their blood sugar, substantially lower their risk of having a heart attack or stroke, and help them lose weight ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback